One Test Will Never Tell the Whole Story
Neurodegenerative diagnostics must move beyond isolated results toward multimodal, patient-centered assessment
-
By
-
Russ Lebovitz
-
September 29, 2026
-
Clinical Scorecard: One Test Will Never Tell the Whole Story
At a Glance
| Category | Detail |
|---|
| Condition | Neurodegenerative Disease |
| Key Mechanisms | Multimodal assessment integrating molecular biomarkers, imaging, and clinical evaluations. |
| Target Population | Patients with neurodegenerative diseases such as Alzheimer's and Parkinson's. |
| Care Setting | Clinical diagnostics and multidisciplinary decision-making. |
Key Highlights
- Single tests cannot fully explain neurodegenerative disease complexities.
- Multimodal assessment integrates various data types for a comprehensive view.
- Longitudinal data is crucial for understanding disease progression.
- Pathologists play an expanded role in interpreting multimodal results.
- Future diagnostics will rely on complementary measures rather than isolated tests.
Guideline-Based Recommendations
Diagnosis
- Use a combination of molecular, imaging, and clinical assessments.
Management
- Integrate findings from various specialties for a comprehensive treatment plan.
Monitoring & Follow-up
- Track changes over time using digital assessments and clinical evaluations.
Risks
- Relying solely on one test may lead to incomplete understanding of the disease.
Patient & Prescribing Data
Individuals diagnosed with neurodegenerative diseases.
Treatment should be guided by a comprehensive understanding of individual patient data.
Clinical Best Practices
- Employ multimodal assessments to capture the complexity of neurodegenerative diseases.
- Facilitate collaboration among neurology, radiology, pathology, and digital data systems.
- Ensure equitable access to diagnostic tools and education for healthcare providers.
Related Resources & Content
